Abstract
We present three patients who developed pronounced redness and scaling in the face, head and neck during treatment with dupilumab indicated for atopic dermatitis (AD). Clinically, these patients suffered from head-neck dermatitis, which is a subtype of AD. Histopathological results showed a remarkable neutrophilic dermatosis with an eczematous background and no characteristics of rosacea. We found an elevated serum level of specific IgE for Malassezia. Treatment with oral itraconazole showed a good clinical response.
Translated title of the contribution | Itraconazole for 'red face' during treatment with dupilumab |
---|---|
Original language | Dutch |
Pages (from-to) | 35-37 |
Number of pages | 3 |
Journal | Nederlands Tijdschrift voor Dermatologie en Venereologie |
Volume | 29 |
Issue number | 4 |
Publication status | Published - 1 Apr 2019 |
Keywords
- Atopic dermatitis
- Dupilumab
- Head and neck dermatitis
- Red face